- Report
- September 2026
- 192 Pages
Global
From €3274EUR$3,545USD£2,739GBP
€3638EUR$3,939USD£3,043GBP
- Report
- September 2026
- 193 Pages
Global
From €3274EUR$3,545USD£2,739GBP
€3638EUR$3,939USD£3,043GBP
- Report
- September 2026
- 187 Pages
Global
From €3274EUR$3,545USD£2,739GBP
€3638EUR$3,939USD£3,043GBP
- Report
- September 2026
- 181 Pages
Global
From €3274EUR$3,545USD£2,739GBP
€3638EUR$3,939USD£3,043GBP
- Report
- September 2026
- 183 Pages
Global
From €3274EUR$3,545USD£2,739GBP
€3638EUR$3,939USD£3,043GBP
- Report
- January 2026
- 194 Pages
Global
From €3274EUR$3,545USD£2,739GBP
€3638EUR$3,939USD£3,043GBP
- Report
- January 2026
- 198 Pages
Global
From €3274EUR$3,545USD£2,739GBP
€3638EUR$3,939USD£3,043GBP
- Report
- February 2026
- 250 Pages
Global
From €4147EUR$4,490USD£3,469GBP
- Report
- November 2026
- 311 Pages
Global
From €5403EUR$5,850USD£4,519GBP
- Report
- November 2026
- 388 Pages
Global
From €5403EUR$5,850USD£4,519GBP
- Report
- November 2026
- 193 Pages
Global
From €5403EUR$5,850USD£4,519GBP
- Report
- November 2026
- 377 Pages
Global
From €5403EUR$5,850USD£4,519GBP
- Report
- November 2026
- 270 Pages
Global
From €5403EUR$5,850USD£4,519GBP
- Report
- November 2026
- 122 Pages
Global
From €5403EUR$5,850USD£4,519GBP
- Report
- November 2026
- 177 Pages
Global
From €5403EUR$5,850USD£4,519GBP
- Report
- November 2026
- 189 Pages
Global
From €5403EUR$5,850USD£4,519GBP
- Report
- November 2026
- 184 Pages
Global
From €5403EUR$5,850USD£4,519GBP
- Report
- November 2026
- 284 Pages
Global
From €5403EUR$5,850USD£4,519GBP
- Report
- November 2026
- 400 Pages
Global
From €5403EUR$5,850USD£4,519GBP
- Report
- November 2026
- 479 Pages
Global
From €5403EUR$5,850USD£4,519GBP

The Ventricular Assist Device (VAD) market is a subset of the Cardiovascular Devices market. VADs are mechanical pumps that are implanted in the body to help the heart pump blood. They are used to treat heart failure, bridge patients to heart transplantation, and provide long-term support for patients with end-stage heart failure. VADs are typically used in patients who are not eligible for heart transplantation or who are waiting for a donor heart.
VADs are classified into two main categories: left ventricular assist devices (LVADs) and right ventricular assist devices (RVADs). LVADs are used to support the left ventricle, while RVADs are used to support the right ventricle. Both types of VADs are designed to improve the quality of life of patients with heart failure.
Some companies in the VAD market include Abiomed, Medtronic, Thoratec, and SynCardia. Show Less Read more